1158 Journal of Natural Products, 2010, Vol. 73, No. 6
Notes
to gel-permeation chromatography over Sephadex LH-20 (50.0 g) made
up in hexanes and eluted with hexanes followed by hexanes-CH2Cl2
(2:1), hexanes-CH2Cl2 (1:1), hexanes-CH2Cl2 (1:2), CH2Cl2,
CH2Cl2-acetone (3:2), CH2Cl2-acetone (1:4), CH2Cl2-MeOH (1:1),
and finally MeOH. Fifteen fractions (60 mL each) were collected and
combined, based on their TLC profiles, to obtain six combined fractions
[F1 (21.8 mg), F2 (22.5 mg), F3-F5 (86.1 mg), F6-F9 (231.1 mg),
F10-F13 (692.6 mg), and F14-F15 (361.3 mg)]. A portion (13.0 mg) of
combined fraction F6-F9 was separated by preparative TLC [eluant:
hexanes-EtOAc (1:9)] to give 6 (5.8 mg, Rf 0.5) and 7 (1.6 mg, Rf
0.3). Combined fraction F10-F13 (300 mg) was chromatographed over
a column of silica gel (10 g) made up in CH2Cl2 and eluted with CH2Cl2
containing increasing amounts of MeOH. A total of 110 fractions (7.5
mL each) were collected, and fractions having similar TLC patterns
were combined to give 10 fractions [A (4.3 mg), B (5.9 mg), C (3.7
mg), D (196.9 mg), E (20.4 mg), F (2.4 mg), G (15.2 mg), H (7.4 mg),
I (2.0 mg), and J (6.2 mg)]. Fraction D (195 mg) was subjected to
column chromatography over LRP-2 (10.0 g) made up in MeOH-H2O
(3:2) and eluted with MeOH-H2O (3:2) followed by MeOH. The first
few fractions from this column were combined to give 8 (33.7 mg),
and the rest of the fractions were combined and subjected to repeated
column chromatography over LRP-2 using CH3CN-H2O (3:7) as eluant
to give additional quantities of 6 (23.8 mg) and 8 (90.2 mg). Fraction
G was further purified by preparative TLC [eluant: i-PrOH-CH2Cl2
(6:94)] to give 5 (11.8 mg, Rf 0.5). A portion (360 mg) of combined
fraction F14-F15 from the first column was chromatographed over a
column of silica gel (25 g) made up in CH2Cl2 and eluted with CH2Cl2
containing increasing amounts of MeOH. A total of 117 fractions (7.0
mL each) were collected, and fractions having similar TLC patterns
were combined to give 10 fractions [K (6.3 mg), L (44.0 mg), M (80.7
mg), N (29.2 mg), O (15.6 mg), P (21.0 mg), Q (2.2 mg), R (5.4 mg),
S (58.5 mg), and T (14.2 mg)]. Fraction O (15.0 mg) was separated on
reversed-phase preparative TLC [eluant: CH3CN-H2O (2:3)] to give
3 (6.7 mg, Rf 0.4). Purification of fraction P (20.0 mg) by silica gel
preparative TLC [eluant: i-PrOH-CH2Cl2 (5:95)] followed by reversed-
phase preparative TLC [eluant: CH3CN-H2O (3:7)] afforded 2 (1.6
mg, Rf 0.5) and 4 (4.5 mg, Rf 0.4). A portion (30 mg) of fraction S was
purified by reversed-phase preparative TLC [eluant: CH3CN-H2O (1:
4)] to yield 1 (20.0 mg, Rf 0.5).
3.98 (3H, s, OCH3), 3.85 (3H, s, OCH3), 2.77 (1H, ddd, J ) 18.7, 2.4,
1.6 Hz, H-4a), 2.48 (1H, dt, J ) 18.7, 3.5 Hz, H-4b), 1.54 (3H, s,
CH3-3); 13C NMR (125 MHz, CDCl3) δ 182.9 (C, C-5), 182.1 (C, C-10),
151.1 (C, C-7), 147.0 (C, C-9), 144.8 (C, C-8), 141.7 (C, C-10a), 137.9
(C, C-4a), 125.6 (C, C-5a), 118.7 (C, C-9a), 105.9 (CH, C-6), 94.1 (C,
C-3), 61.4 (CH3, OCH3-9), 58.0 (CH3, OCH3-7), 56.5 (CH2, C-1), 31.9
(CH2, C-4), 28.8 (CH3, CH3-3); HRFABMS m/z 319.0819 [M - 1]-
(calcd for C16H15O7, 319.0823).
Scytalol A (4): white solid (CH2Cl2-hexanes); mp 166-168 °C
(lit.16 165-169 °C); [R]2D5 +86 (c 1.0, MeOH) [lit.16 +89 (c 0.9,
MeOH)]; 1H NMR and MS data were consistent with reported data.16
Methylation of Scytalol A (4). To a solution of 4 (2 mg) in acetone
(0.2 mL) were added Me2SO4 (10 µL) and K2CO3 (10 mg), and the
mixture was stirred at 80 °C. After 2 h the reaction mixture was filtered,
the filtrate evaporated under reduced pressure, and the product purified
by preparative TLC (8% i-PrOH in CH2Cl2) to afford a product (1.35
mg) that was found to be identical (TLC, [R]D, LC-MS, and 1H NMR)
with 9-O-methylscytalol A (1) obtained above.
8-O-Methylfusarubin (5): red solid; mp 139-140 °C (lit.18a
1
138-139 °C); H NMR and MS data were consistent with reported
data.18
Scorpinone (6): yellow solid (CH2Cl2-hexanes); mp 294-296 °C
(lit.19 295 °C); 1H NMR, 13C NMR, and MS data were consistent with
reported data.19
8-O-Methylbostrycoidin (7): maroon solid (CH2Cl2-hexanes); mp
213-215 °C (lit.18a 215-216 °C); H NMR, 13C NMR, and MS data
1
were consistent with reported data.18
Herbarin (8): yellow solid (CH2Cl2-hexanes); mp 191-193 °C
(lit.4 190-192 °C); 1H NMR and MS data were consistent with reported
data.4,17
Isolation of Metabolites of Corynespora sp. BA-10763 Cultured
in 2% MEA. The fungal strain was cultured in 20 T-flasks (800 mL),
each containing 135 mL of MEA coated on five sides of the flasks
(total surface area/flask ca. 460 cm2). After incubation for 14 days at
28 °C, cultures were processed as for PDA (see above) to afford the
EtOAc extract as a dark brown solid (144 mg). The majority (143 mg)
of this extract was subjected to column chromatography over silica
gel (10 g) made up in CH2Cl2 and eluted with CH2Cl2 containing
increasing amounts of MeOH followed by 100% MeOH. Fifty-six
fractions (7 mL each) were collected, and fractions having similar TLC
patterns were combined to give 12 major fractions (F1-F12). Fraction
2 (F2) was purified by reversed-phase preparative TLC [eluant:
CH3CN-H2O (3:2)] to give 10 (1.4 mg, Rf 0.6). The major fraction
(F6) was separated by reversed-phase preparative TLC [eluant:
CH3CN-H2O (3:2)] to give an additional quantity (1.8 mg) of 10 (Rf
0.4) together with 6 (1.6 mg, Rf 0.3), 8 (6.2 mg, Rf 0.8), and 9 (17.8
mg, Rf 0.7). Fraction 7 (F7) was purified by reversed-phase preparative
TLC [eluant: CH3CN-H2O (3:2)] to give an additional amount of 9
(16.5 mg).
9-O-Methylscytalol A (1): off-white solid (CH2Cl2-hexanes); mp
172-174 °C; [R]2D5 +92 (c 1.1, MeOH); UV (EtOH) λmax (log ε) 309
(3.64), 276 (4.11), 231 (4.10) nm; IR νmax 3411, 1658, 1598, 1569,
1456, 1326, 1218, 1203, 1161, 1051, 1020 cm-1; 1H NMR (500 MHz,
CDCl3) δ 6.87 (1H, dd, J ) 2.2 and 0.8 Hz, H-6), 6.37 (1H, d, J ) 2.2
Hz, H-8), 4.41 (1H, brd, J ) 7.3 Hz, H-5), 4.12 (1H, dd, J ) 11.7 and
4.3 Hz, H-1a), 3.96 (1H, dd, J ) 11.7 and 10.1 Hz, H-1b), 3.85 (3H,
s, OCH3), 3.84 (3H, s, OCH3), 2.39-2.28 (4H, m, H2-4, H-4a and
H-10a), 1.46 (3H, s, CH3-3); 13C NMR (125 MHz, CDCl3) δ 194.2 (C,
C-10), 164.6 (C, C-7), 162.2 (C, C-9), 150.9 (C, C-5a), 114.1 (C, C-9a),
102.2 (CH, C-6), 98.1 (CH, C-8), 95.1 (C, C-3), 73.0 (CH, C-5), 59.9
(CH2, C-1), 55.8 (CH3, OCH3), 55.5 (CH3, OCH3), 47.5 (CH, C-10a),
40.8 (CH, C-4a), 38.3 (CH2, C-4), 29.9 (CH3, Me); HRFABMS m/z
309.1331 [M + 1]+ (calcd for C16H21O6, 309.1333).
1-Hydroxydehydroherbarin (9): orange, amorphous solid; 1H NMR
and MS data were consistent with reported data.4
1-Methoxydehydroherbarin (10): orange solid (CH2Cl2-hexanes);
mp 166-168 °C; UV (EtOH) λmax (log ε) 446 (1.19), 422 (4.10), 336
(4.28), 276 (4.85) nm; IR νmax 1682, 1586, 1320, 1162, 1063 cm-1; 1H
NMR (500 MHz, CDCl3) δ 7.26 (1H, d, J ) 2.5 Hz, H-6), 6.71 (1H,
d, J ) 2.5 Hz, H-8), 6.62 (1H, s. H-4), 6.04 (1H, s, H-1), 3.94 (3H, s,
OMe), 3.93 (3H, s, OMe), 3.57 (3H, s, OMe), 2.11 (3H, s, H-3);
HRFABMS m/z 317.1023 [M + 1]+ (calcd for C17H17O6 317.1020).
7-Desmethylherbarin (2): orange solid (acetone-hexanes); mp
176-178 °C; UV (EtOH) λmax (log ε) 445 (4.01), 427 (3.95), 334 (4.26),
280 (4.94) nm; IR νmax 3480, 1656, 1580, 1567, 1490, 1325, 1230,
1
1170 cm-1; H NMR (500 MHz, acetone-d6) δ 7.12 (1H, d, J ) 2.2
Hz, H-6), 6.78 (1H, d, J ) 2.2 Hz, H-8), 4.54 (2H, m, H-1a and H-1b),
3.87 (3H, s, OCH3), 2.66 (1H, dt, J ) 18.3, 1.8 Hz, H-4a), 2.41 (1H,
dt, J ) 18.3, 3.3 Hz, H-4b), 1.50 (3H, s, CH3-3); 13C NMR (125 MHz,
CDCl3) δ 184.7 (C, C-10), 181.1 (C, C-5), 163.4 (C, C-7 and C-9),
143.9 (C, C-5a), 137.5 (C, C-4a), 136.8 (C, C-10a), 113.1 (C, C-9a),
107.4 (CH, C-6), 105.1 (CH, C-8), 94.4 (C, C-3), 58.7 (CH2, C-1),
56.3 (CH3, OCH3), 32.9 (CH2, C-4), 28.9 (CH3, CH3-3); HRFABMS
m/z 289.0714 [M - 1]- (calcd for C15H13O6, 289.0718).
Acknowledgment. Financial support for this work from the National
Cancer Institute (Grant 5R01CA 90265-07) is gratefully acknowledged.
References and Notes
(1) Studies on Arid Lands Plants and Microorganisms, Part 20. For Part
19, see:Bashyal, B. P.; Gunatilaka, A. A. L. Nat. Prod. Res. 2010,
29, 349–356.
(2) (a) Schmidt, E. W. Nat. Chem. Biol. 2008, 4, 466–473. (b) Miller,
S. J.; Clardy, J. Nat. Chem. 2009, 1, 261–263. (c) Gunatilaka, A. A. L.
J. Nat. Prod. 2006, 69, 509–526. (d) Zhang, H. W.; Song, Y. C.; Tan,
R. X. Nat. Prod. Rep. 2006, 23, 753–771.
(3) Arnold, A. E. Fungal Biol. ReV. 2007, 21, 51–66.
(4) Paranagama, P. A.; Wijeratne, E. M. K.; Burns, A. M.; Marron, M. T.;
Gunatilaka, M. K.; Arnold, A. E.; Gunatilaka, A. A. L. J. Nat. Prod.
2007, 70, 1700–1705.
(5) Ding, G.; Li, Y.; Fu, S.; Liu, S.; Wei, J.; Che, Y. J. Nat. Prod. 2009,
72, 182–186.
Methylation of 7-Desmethylherbarin (2). To a solution of 2 (0.5
mg) in acetone (0.5 mL) were added CH3I (0.05 mL) and K2CO3 (2.0
mg), and the mixture was stirred at 25 °C for 3 h. The reaction mixture
was filtered and evaporated under reduced pressure. The product (0.5
1
mg) formed was shown to be identical (TLC, LC-MS, and H NMR)
with herbarin (8).4,17
8-Hydroxyherbarin (3): orange solid (CH2Cl2-hexanes); mp
163-165 °C; UV (EtOH) λmax (log ε) 375 (3.80), 276 (4.71), 213 (4.69)
nm; IR νmax 3433, 1654, 1589, 1564, 1492, 1330, 1226, 1166 cm-1
;
1H NMR (500 MHz, CDCl3) δ 7.40 (1H, s, H-6), 4.64 (2H, m, H2-1),